Dorado, C.Q.; RamÃrez, A.S.; Pérez, M.P.; Centeno, M.S.; Mici, L.P.; Güemez, C.M.; Albers Acosta, E.; Luis, G.C.; Costal, M.; Diez, P.T.;
et al. Redefining Prostate Cancer Precision: Radiogenomics, Theragnostics, and AI-Driven Biomarkers. Cancers 2025, 17, 3747.
https://doi.org/10.3390/cancers17233747
AMA Style
Dorado CQ, RamÃrez AS, Pérez MP, Centeno MS, Mici LP, Güemez CM, Albers Acosta E, Luis GC, Costal M, Diez PT,
et al. Redefining Prostate Cancer Precision: Radiogenomics, Theragnostics, and AI-Driven Biomarkers. Cancers. 2025; 17(23):3747.
https://doi.org/10.3390/cancers17233747
Chicago/Turabian Style
Dorado, Cristina Quicios, Ana Sánchez RamÃrez, Marta Pérez Pérez, Manuel Saavedra Centeno, Lira Pelari Mici, Carlos Márquez Güemez, Eduardo Albers Acosta, Guillermo Celada Luis, Martin Costal, Patricia Toquero Diez,
and et al. 2025. "Redefining Prostate Cancer Precision: Radiogenomics, Theragnostics, and AI-Driven Biomarkers" Cancers 17, no. 23: 3747.
https://doi.org/10.3390/cancers17233747
APA Style
Dorado, C. Q., RamÃrez, A. S., Pérez, M. P., Centeno, M. S., Mici, L. P., Güemez, C. M., Albers Acosta, E., Luis, G. C., Costal, M., Diez, P. T., Laorden, N. R., DÃaz, R. J., Velasco Balanza, C., & Manso, L. S. J.
(2025). Redefining Prostate Cancer Precision: Radiogenomics, Theragnostics, and AI-Driven Biomarkers. Cancers, 17(23), 3747.
https://doi.org/10.3390/cancers17233747
